Home » GLAXO TO CHALLENGE HERCEPTIN AT TOP CANCER MEETING
GLAXO TO CHALLENGE HERCEPTIN AT TOP CANCER MEETING
May 24, 2006
GlaxoSmithKline Plc hopes to grab the headlines at the world's top cancer meeting early next month with a barrage of data, including key trial results for a new breast cancer pill challenging blockbuster Herceptin.
The Scotsman (http://business.scotsman.com/latest.cfm?id=771632006)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct